Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Moderna Therapeutics
Merck
vaccines
Keytruda
melanoma
MRNA
Merck suffers bad week as 3 Keytruda combination trials fail
BioPharma Dive
Sun, 12/10/23 - 11:19 pm
Merck
Keytruda
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer
Fierce Pharma
Thu, 12/7/23 - 12:00 pm
Merck
Keytruda
non-small cell lung cancer
Lynparza
AstraZeneca
Merck Expands Keytruda’s Label as a First-Line Option for Gastric Cancer
BioSpace
Fri, 11/17/23 - 11:48 am
Merck
Keytruda
gastric cancer
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Merck
AstraZeneca
biliary tract cancer
Keytruda
Imfinzi
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
ESMO
Merck
Bristol Myers Squibb
bladder cancer
PD-1 inhibitors
Keytruda
Padcev
Opdivo
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
ESMO
Bristol Myers Squibb
Opdivo
bladder cancer
Padcev
Keytruda
Merck
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
Fri, 10/20/23 - 11:47 am
Merck
GSK
Keytruda
Jemperli
ESMO
nonsquamous non-small cell lung cancer
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:42 am
Seagen
Astellas
Merck
Padcev
Keytruda
bladder cancer
ESMO
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval
BioSpace
Tue, 10/17/23 - 09:36 pm
Merck
Keytruda
non-small cell lung cancer
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Merck
Keytruda
non-small cell lung cancer
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Merck
Keytruda
bladder cancer
muscle-invasive urothelial carcinoma
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Merck
Seagen
Astellas
urothelial cancer
clinical trials
bladder cancer
Padcev
Keytruda
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Merck
Keytruda
FDA
cervical cancer
priority review
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Fri, 08/25/23 - 09:55 am
Merck
Keytruda
Roche
branding
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Fierce Pharma
Mon, 08/21/23 - 10:52 am
Merck
Roche
pharma sales
Keytruda
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »